Accuray ROA 2006-2018 | ARAY

Current and historical return on assets (ROA) values for Accuray (ARAY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Accuray ROA for the three months ending September 30, 2018 was -5.17%.
Accuray ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.02B $0.37B -6.20%
2018-06-30 $-0.02B $0.38B -6.10%
2018-03-31 $-0.03B $0.39B -7.00%
2017-12-31 $-0.02B $0.41B -5.89%
2017-09-30 $-0.03B $0.39B -6.86%
2017-06-30 $-0.03B $0.41B -6.98%
2017-03-31 $-0.03B $0.42B -7.19%
2016-12-31 $-0.03B $0.42B -5.56%
2016-09-30 $-0.02B $0.42B -4.74%
2016-06-30 $-0.03B $0.47B -5.28%
2016-03-31 $-0.02B $0.49B -5.07%
2015-12-31 $-0.03B $0.47B -6.00%
2015-09-30 $-0.03B $0.46B -6.88%
2015-06-30 $-0.04B $0.47B -8.82%
2015-03-31 $-0.05B $0.46B -9.54%
2014-12-31 $-0.05B $0.47B -9.82%
2014-09-30 $-0.04B $0.46B -8.70%
2014-06-30 $-0.04B $0.50B -7.41%
2014-03-31 $-0.05B $0.49B -9.35%
2013-12-31 $-0.07B $0.49B -14.71%
2013-09-30 $-0.10B $0.47B -20.41%
2013-06-30 $-0.10B $0.48B -22.55%
2013-03-31 $-0.10B $0.50B -22.81%
2012-12-31 $-0.09B $0.42B -19.34%
2012-09-30 $-0.07B $0.44B -14.56%
2012-06-30 $-0.07B $0.47B -14.71%
2012-03-31 $-0.08B $0.49B -15.87%
2011-12-31 $-0.06B $0.49B -14.74%
2011-09-30 $-0.05B $0.50B -13.30%
2011-06-30 $-0.03B $0.46B -8.79%
2011-03-31 $0.00B $0.26B 1.16%
2010-12-31 $0.01B $0.26B 2.33%
2010-09-30 $0.00B $0.25B 0.39%
2010-06-30 $0.00B $0.26B 1.15%
2010-03-31 $-0.00B $0.26B -0.38%
2009-12-31 $-0.00B $0.26B -0.75%
2009-09-30 $0.00B $0.26B 0.00%
2009-06-30 $0.00B $0.27B 0.00%
2009-03-31 $-0.00B $0.27B -0.35%
2008-12-31 $-0.00B $0.29B -0.35%
2008-09-30 $0.00B $0.28B 0.00%
2008-06-30 $0.01B $0.30B 1.64%
2008-03-31 $0.01B $0.29B 1.91%
2007-12-31 $0.00B $0.31B 1.25%
2007-09-30 $-0.01B $0.32B -1.79%
2007-06-30 $-0.01B $0.33B -2.51%
2007-03-31 $-0.01B $0.32B -12.04%
2006-12-31 $-0.02B $0.14B -58.33%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.413B $0.405B
ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $95.145B 22.17
Intuitive Surgical (ISRG) United States $57.557B 56.63
Edwards Lifesciences (EW) United States $30.897B 33.06
Fresenius Medical Care AG KGaA (FMS) Germany $24.056B 16.29
IDEXX Laboratories (IDXX) United States $17.145B 48.97
ABIOMED (ABMD) United States $15.217B 109.34
DexCom (DXCM) United States $12.599B 0.00
Teleflex (TFX) United States $11.921B 27.06
Hologic (HOLX) United States $11.149B 18.29
Varian Medical Systems (VAR) United States $10.796B 26.74
STERIS (STE) United Kingdom $10.135B 26.89
Masimo (MASI) United States $5.890B 38.20
LivaNova (LIVN) United Kingdom $5.615B 36.04
Globus Medical (GMED) United States $5.071B 31.86
Penumbra (PEN) United States $4.749B 286.77
Integra LifeSciences Holdings (IART) United States $4.600B 22.41
Wright Medical Group (WMGI) Netherlands $3.691B 0.00
Cantel Medical (CMD) United States $3.469B 34.94
Inogen (INGN) United States $2.988B 64.48
Integer Holdings (ITGR) United States $2.709B 22.67
Halyard Health (AVNS) United States $2.351B 21.18
OPKO Health (OPK) United States $2.085B 0.00
Glaukos (GKOS) United States $1.995B 0.00
Tandem Diabetes Care (TNDM) United States $1.877B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.290B 0.00
Nevro (NVRO) United States $1.232B 0.00
Luminex (LMNX) United States $1.174B 42.48
Pacific Biosciences Of California (PACB) United States $1.139B 0.00
Orthofix (OFIX) United States $1.129B 32.60
Tactile Systems Technology (TCMD) United States $1.125B 179.18
CryoLife (CRY) United States $1.088B 95.42
Natus Medical (BABY) United States $1.009B 21.18
Intersect ENT (XENT) United States $0.909B 0.00
Accelerate Diagnostics (AXDX) United States $0.785B 0.00
AngioDynamics (ANGO) United States $0.783B 27.40
Mesa Laboratories (MLAB) United States $0.765B 45.22
TransEnterix (TRXC) United States $0.646B 0.00
Veracyte (VCYT) United States $0.544B 0.00
Sientra (SIEN) United States $0.504B 0.00
ViewRay (VRAY) United States $0.460B 0.00
SI-BONE INC (SIBN) United States $0.422B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.410B 0.00
Neuronetics (STIM) United States $0.387B 0.00
OrthoPediatrics (KIDS) United States $0.340B 0.00
Quotient (QTNT) Switzerland $0.332B 0.00
SeaSpine Holdings (SPNE) United States $0.318B 0.00
Nuvectra (NVTR) United States $0.307B 0.00
Fluidigm (FLDM) United States $0.298B 0.00
RTI Surgical (RTIX) United States $0.286B 45.00
IRadimed (IRMD) United States $0.278B 72.54
GenMark Diagnostics (GNMK) United States $0.247B 0.00
Corindus Vascular Robotics (CVRS) United States $0.243B 0.00
CRH Medical (CRHM) Canada $0.239B 41.25
Helius Medical Technologies (HSDT) United States $0.233B 0.00
Pulse Biosciences (PLSE) United States $0.223B 0.00
T2 Biosystems (TTOO) United States $0.214B 0.00
Ekso Bionics Holdings (EKSO) United States $0.132B 0.00
Alphatec Holdings (ATEC) United States $0.127B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.108B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Ra Medical Systems (RMED) United States $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.100B 0.00
Apollo Endosurgery (APEN) United States $0.086B 0.00
Restoration Robotics (HAIR) United States $0.076B 0.00
Biosig Technologies (BSGM) United States $0.070B 0.00
Viveve Medical (VIVE) United States $0.068B 0.00
EDAP TMS (EDAP) France $0.068B 0.00
Electromed (ELMD) United States $0.054B 27.13
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Xtant Medical Holdings (XTNT) United States $0.041B 0.00
Vermillion (VRML) United States $0.038B 0.00
Neovasc (NVCN) Canada $0.037B 0.00
ConforMIS (CFMS) United States $0.036B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.034B 0.00
PAVmed (PAVM) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.029B 0.00
DarioHealth (DRIO) Israel $0.029B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.022B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
American Shared Hospital Services (AMS) United States $0.017B 12.70
Nanovibronix (NAOV) United States $0.016B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Presbia (LENS) Ireland $0.013B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00